25692 Federal Register / Vol. 80, No. 86 / Tuesday, May 5, 2015 / Notices 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters for Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Evaluating Structural, 

Economic, Environmental, or Policy Primary 

Prevention Strategies for Intimate Partner 

Violence and Sexual Violence’’, CE–15–003. 

Contact Person for More Information: 

Gwendolyn Cattledge, Ph.D., M.S.E.H., 

Scientific Review Officer, CDC, 4770 Buford 

Hwy. NE., Mailstop E63, Atlanta, Georgia 

30341–3724, Telephone: 770–488–4655. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

Pertaining to announcements of meetings and 

other committee Management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Catherine Ramadei, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–10416 Filed 5–4–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting for the initial 

review of applications in response to 

Special Interest Project (SIP) 15–006, 

Building Local Community Health 

Leadership for Action on Preventing 

Chronic Disease. 

Time and Date: 10:00 a.m.–6:00 p.m., EDT, 

May 28, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters for Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Building Local Community 

Health Leadership for Action on Preventing 

Chronic Disease’’, SIP 15–006. 

Contact Person for More Information: 

Brenda Colley Gilbert, Ph.D., M.S.P.H., 

Director, Extramural Research Program 

Operations and Services, CDC, 4770 Buford 

Highway NE., Mailstop F–80, Atlanta, 

Georgia 30341, Telephone: (770) 488–6295, 

BJC4@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Catherine Ramadei, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–10417 Filed 5–4–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting for the initial 

review of applications in response to 

Funding Opportunity Announcement 

(FOA), RFA–CE–15–004, Evaluating 

Innovative and Promising Strategies to 

prevent Suicide among Middle-Aged 

Men. 

Time and Date: 12:00 p.m.–5:00 p.m., EDT, 

June 2, 2015 (CLOSED). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters for Discussion: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Evaluating Innovative and 

Promising Strategies to prevent Suicide 

among Middle-Aged Men’’, CE–15–004. 

Contact Person for More Information: 

Gwendolyn Cattledge, Ph.D., M.S.E.H., 

Scientific Review Officer, CDC, 4770 Buford 

Hwy. NE., Mailstop E63, Atlanta, Georgia 

30341–3724, Telephone: (770) 488–4655. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Catherine Ramadei, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–10415 Filed 5–4–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number CDC–2015–0026; NIOSH 

248–B] 

World Trade Center Health Program 

Scientific/Technical Advisory 

Committee (WTCHP STAC or Advisory 

Committee), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 10:00 a.m.–4:45 p.m., June 

4, 2015 (All times are Eastern Daylight 

Savings Time). 

Place: Jacob J. Javits Federal Building, 26 

Federal Plaza, New York, New York 10278. 

This meeting is also available by 

teleconference. The USA toll-free, dial-in 

number is 1–888–810–6754, and when 

prompted enter passcode—1908415. To view 

the web conference, enter the following web 

address in your web browser: https://

odniosh.adobeconnect.com/wtcstacjune4/. 

Public Comment Time and Date: 1:30 

p.m.–2:00 p.m., June 4, 2015. 

Please note that the public comment period 

ends at the time indicated above or following 

the last call for comments, whichever is 

earlier. Members of the public who want to 

comment must sign up by providing their 

name by mail, email, or telephone, at the 

addresses provided below by May 29, 2015. 

Each commenter will be provided up to five 

minutes for comment. A limited number of 

time slots are available and will be assigned 

on a first come, first served basis. Written 

comments will also be accepted from those 

unable to attend the public session. 

Status: Open to the public, limited only by 

the number of telephone lines. The 

conference line will accommodate up to 100 

callers; therefore it is suggested that those 

interested in calling in to listen to the 

committee meeting share a line when 

possible. 

Background: The Advisory Committee was 

established by Public Law 111–347 (The 

James Zadroga 9/11 Health and 

Compensation Act of 2010, Title XXXIII of 

the Public Health Service Act), enacted on 

January 2, 2011 and codified at 42 U.S.C. 

300mm–300mm–61. 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 86 / Tuesday, May 5, 2015 / Notices 25693 

Purpose: The purpose of the Advisory 

Committee is to review scientific and 

medical evidence and to make 

recommendations to the Administrator of the 

World Trade Center (WTC) Health Program 

regarding additional WTC Health Program 

eligibility criteria and potential additions to 

the list of covered WTC-related health 

conditions, as well as providing consultation 

on research to the Administrator of the World 

Trade Center Health Program. Title XXXIII of 

the Public Health Service Act established 

within the Department of Health and Human 

Services (HHS), the World Trade Center 

(WTC) Health Program, to be administered by 

the Administrator of the World Trade Center 

Health Program. The WTC Health Program 

provides: (1) Medical monitoring and 

treatment benefits to eligible emergency 

responders and recovery and cleanup 

workers (including those who are Federal 

employees) who responded to the September 

11, 2001, terrorist attacks, and (2) initial 

health evaluation, monitoring, and treatment 

benefits to residents and other building 

occupants and area workers in New York 

City, who were directly impacted and 

adversely affected by such attacks 

(‘‘survivors’’). Certain specific activities of 

the Administrator of the World Trade Center 

Health Program are reserved to the Secretary, 

HHS, to delegate at her discretion; other 

duties of the Administrator of the World 

Trade Center Health Program not explicitly 

reserved to the Secretary, HHS, are assigned 

to the Director, NIOSH. The administration of 

the Advisory Committee established under 

section 300mm–1(a) is delegated to the 

Director of NIOSH in his role as 

Administrator of the World Trade Center 

Health Program. CDC and NIOSH provide 

funding, staffing, and administrative support 

services for the Advisory Committee. The 

charter was reissued on May 12, 2013, and 

will expire on May 12, 2015. The charter 

renewal is currently in process. 

Matters for Discussion: The agenda for the 

Advisory Committee meeting includes a 

review of the World Trade Center Health 

Program’s (WTCHP) structure and function, 

activities, member services, and 

communications. An overview of the WTC 

health research, the WTC Registry, and 

lessons learned in addressing WTC-related 

mental health issues will also be presented. 

The Advisory Committee will deliberate on 

specific questions related to: (1) Addressing 

the need for research on developmental or 

health effects in children; (2) developing 

robust and appropriate comparison groups to 

improve the validity and interpretability of 

WTC research; (3) improving benefits 

counseling and psychosocial support for 

members serviced by the National Provider 

Network; and (4) reviewing the WTCHP’s 

‘‘Research-to-Care’’ model. 

The agenda is subject to change as 

priorities dictate. 

To view the notice, visit http://

www.regulations.gov and enter CDC–2015– 

0026 in the search field and click ‘‘Search.’’ 

Public Comment Sign-up and Submissions 

to the Docket: To sign up to provide public 

comments or to submit comments to the 

docket, send information to the NIOSH 

Docket Office by one of the following means: 

Mail: NIOSH Docket Office, Robert A. Taft 

Laboratories, MS–C–34, 1090 Tusculum 

Avenue, Cincinnati, Ohio 45226. 

Email: nioshdocket@cdc.gov. 

Telephone: (513) 533–8611. 

In the event an individual cannot attend, 

written comments may be submitted. The 

comments should be limited to two pages 

and submitted through http://

www.regulations.gov by May 29, 2015. Efforts 

will be made to provide the two-page written 

comments received by the deadline below to 

the committee members before the meeting. 

Comments in excess of two pages will be 

made publicly available at http://

www.regulations.gov. To view background 

information and previous submissions go to 

NIOSH docket http://www.cdc.gov/niosh/

docket/archive/docket248.html and http://

www.cdc.gov/niosh/docket/archive/

docket248-A.html. 

Policy on Redaction of Committee Meeting 

Transcripts (Public Comment): Transcripts 

will be prepared and posted to http://

www.regulations.gov within 60 days after the 

meeting. If a person making a comment gives 

his or her name, no attempt will be made to 

redact that name. NIOSH will take reasonable 

steps to ensure that individuals making 

public comments are aware of the fact that 

their comments (including their name, if 

provided) will appear in a transcript of the 

meeting posted on a public Web site. Such 

reasonable steps include a statement read at 

the start of the meeting stating that 

transcripts will be posted and names of 

speakers will not be redacted. If individuals 

in making a statement reveal personal 

information (e.g., medical information) about 

themselves, that information will not usually 

be redacted. The CDC Freedom of 

Information Act coordinator will, however, 

review such revelations in accordance with 

the Freedom of Information Act and, if 

deemed appropriate, will redact such 

information. Disclosures of information 

concerning third party medical information 

will be redacted. 

Contact Person for More Information: Paul 

J. Middendorf, Ph.D., Designated Federal 

Officer, NIOSH, CDC, 2400 Century Parkway 

NE., Mail Stop E–20, Atlanta, Georgia 30345, 

telephone 1 (888) 982–4748; email: wtc-stac@

cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Catherine Ramadei, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–10418 Filed 5–4–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, (BSC) 

National Center for Environmental 

Health/Agency for Toxic Substances 

and Disease Registry (NCEH/ATSDR) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 8:30 a.m.–5:00 p.m., 

EDT, June 3, 2015; 8:30 a.m.–11:45 a.m., 

EDT, June 4, 2015. 

Place: CDC, 4770 Buford Highway, Atlanta, 

Georgia 30341. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 60 people. 

Purpose: The Secretary, Department of 

Health and Human Services (HHS) and by 

delegation, the Director, CDC and 

Administrator, NCEH/ATSDR, are authorized 

under Section 301 (42 U.S.C. 241) and 

Section 311 (42 U.S.C. 243) of the Public 

Health Service Act, as amended, to: (1) 

Conduct, encourage, cooperate with, and 

assist other appropriate public authorities, 

scientific institutions, and scientists in the 

conduct of research, investigations, 

experiments, demonstrations, and studies 

relating to the causes, diagnosis, treatment, 

control, and prevention of physical and 

mental diseases and other impairments; (2) 

assist states and their political subdivisions 

in the prevention of infectious diseases and 

other preventable conditions and in the 

promotion of health and well being; and (3) 

train state and local personnel in health 

work. The BSC, NCEH/ATSDR provides 

advice and guidance to the Secretary, HHS; 

the Director, CDC and Administrator, 

ATSDR; and the Director, NCEH/ATSDR, 

regarding program goals, objectives, 

strategies, and priorities in fulfillment of the 

agency’s mission to protect and promote 

people’s health. The board provides advice 

and guidance that will assist NCEH/ATSDR 

in ensuring scientific quality, timeliness, 

utility, and dissemination of results. The 

board also provides guidance to help NCEH/ 

ATSDR work more efficiently and effectively 

with its various constituents and to fulfill its 

mission in protecting America’s health. 

Matters for Discussion: The agenda items 

for the BSC Meeting will include NCEH/ 

ATSDR Office of the Director updates; CDC/ 

ATSDR Activities on Household Air 

Pollution and Cleaner Cookstoves; NCEH/ 

ATSDR Program Responses to BSC Guidance 

and Action Items; At the Intersection of 

Public Health and Health Care: CDC’s 

National Asthma Control Program; 

Environmental Health Services: Vessel 

Sanitation Program, Model Aquatic Health 

Code; Geospatial Research, Analysis, and 

Services Program; NCEH/ATSDR Emergency 

Management Activities; Environmental 

Health Tracking Program; Advances in 


asabaliauskas on DSK5VPTVN1PROD with NOTICES